Journals / Göztepe Tıp Dergisi / 2008 / Cilt: 23 - Sayı: 2

Porphyria disease and anaesthesia

Porfiri hastalığı ve anestezi

Pages
70–72
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We wanted to emphasize which anesthesia method is safer at a patient which has diagnosed as porphyria.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Porphyria is a result of a spesific enzyme deficiency at hem biosenthesis steps.
📊
Key Findings & Data:The precursors are ALA and PBG at porfirin synthesis and the disorders at these steps are named as porphyria.Acute porphyrias are metabolic disorders at biochemical processes on liver.
💡
Conclusion & Impact:We wanted to emphasize which anesthesia method is safer at a patient which has diagnosed as porphyria.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Porphyria is a result of a spesific enzyme deficiency at hem biosenthesis steps. The precursors are ALA and PBG at porfirin synthesis and the disorders at these steps are named as porphyria.Acute porphyrias are metabolic disorders at biochemical processes on liver. Porphyria disease is very important for anaesthetists. We wanted to emphasize which anesthesia method is safer at a patient which has diagnosed as porphyria.

Özet

Porfiri, hem biyosentez basamaklarındaki özgül bir enzim eksikliğinden kaynaklanır.Porfirin sentezinde öncü maddeler ALA ve PBG olup, bu sentez basamaklarındaki bozukluklar sonucu meydana gelen tablo “ Porfiri” olarak adlandırılır.Akut porfiriler esas olarak karaciğerdeki biyokimyasal işlemleri etkileyen metabolik bozukluklardır. Porfiri hastalığı anestezi yönünden dikkat edilmesi gereken bir hastalık olup, porfiri tanısı almış olan bir hastada nasıl bir anestezi yöntemi kullanılmasının daha güvenli olacağını sunmayı amaçladık.

🔖

Cite This Article

ÇELİK, M., DEVRİM, S., YALMAN, A., ARPAZ, O. (2022). Porphyria disease and anaesthesia. Göztepe Tıp Dergisi, Cilt: 23 - Sayı: 2, 70–72. https://ajindex.com/articles/526278

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. http://www.porphyria-europe.org available at: http://www.porphyria-europe.org/02-for-healthcare/the-porphyrias.asp (06/06/2007
  2. Harrison GG, Meissner PN, Hift RJ: Anaesthesia for the porphyric patient. Anaesthesia 48:417-21, 1993
  3. Moore MR, McColl KEL, Remington C, Goldberg A: Disorders of porphyrin metabolism. New York: Plenum Medical Book Company, 1987
  4. Yeung Laiwah AC, McColl KEL: Management of attacks of acute porphyria. Drugs 34:604-16, 1987
  5. Ward RJ: Porphyria and its relation to anesthesia. Anesthesiology 26:212-5, 1965
  6. Meissner PN, Jarrison GG, Hift RJ: Propofol as an I.V. anaesthetic induction agent in variegate porphyria. Br J Anaesth 66:60-5, 1991
  7. Hift RJ, Meissner PN, Meissner DM: Porphyria: a guide for people with porphyria and their doctors. Johannesburg: MRC/UCT Liver Research Centre 1-45, 1991
  8. Disler PB, Eales L: The acute attack of porphyria. S Afr Med J 61:82-4, 1982
  9. Mustajoki P, Heinonen J: General anesthesia in “inducible” porphyrias. Anesthesiology 53:15-20, 1980
  10. Harrison GG, Moore MR, Meissner PN: Porphyrinogenicity of etomidate and ketamine as continuous infusions. Br J Anesth 57:420-3, 1985
  11. Famewo CE: Induction of anesthesia with etomidate in a patient with acute intermittent porphyria. Can Anesth Soc Jc 32:171-3, 1985
  12. Hodkinson B: Porphyria and propofol. Anaesthesia 89:613, 1989
  13. Hughes PJ: Propofol in acute porphyrias. Anaesthesia 45:415-6, 1990
  14. Bohrer H, Schmidt H, Augenstein T, et al: Porphyrinogenicity and metabolic effects of propofol in am AIA-primed rat model. Eur J Anaesthesio 8:486, 1991
  15. Buzaleh A, De Salamanca R, Del C Battle A: Porphyrinogenic properties of the anesthetic enflurane. Gen Pharmacol 23:665-9, 1992.